查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553512

经导管肺动脉瓣市场规模、份额、趋势分析报告：按应用、按技术、按最终用途、按原材料、按地区、细分市场预测，2024-2030年

Transcatheter Pulmonary Valve Market Size, Share & Trends Analysis Report By Application (Pulmonary Stenosis, Pulmonary Regurgitation), By Technology, By End-use, By Raw Material, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格
简介目录

经导管肺动脉瓣市场的成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球经导管肺动脉瓣市场规模将达到1.006亿美元，2024年至2030年复合年增长率为5.5%。

心臟瓣膜技术的技术进步、各种上市和私人公司临床试验管道的增加是预计在预测期内推动市场发展的一些关键因素。

2023年，北美将占据全球大部分市场占有率，约80.6%。主要驱动因素包括各种心血管疾病的盛行率不断增加、患有心臟瓣膜疾病（如肺动脉瓣狭窄、肺动脉瓣逆流）的老年人口不断增加，以及人们对经导管瓣膜相对于外科手术的优势的认识不断增加。患有长期心臟病的患者数量不断增加，对技术先进的心臟瓣膜的认识不断提高，以及整体经导管瓣膜的医疗支出和报销政策的增加是推动全球市场成长的主要因素。

然而，由于计划推出多项产品，预计从 2019 年起，亚太地区该市场将出现成长。由于日本和中国等许多新兴经济体的成长，亚太地区预计将以良好的成长率成长。由于人口老化和心臟病盛行率上升等多种因素，这些新兴国家展现出成长潜力。此外，大量患者的存在、医疗基础设施和服务的发展、可支配收入的增加、政府资金的增加等都是预计在预测期内推动市场的一些因素。

经导管肺动脉瓣市场报告亮点

  • 肺动脉狭窄在市场上占据主导地位，2023年市场占有率为43.1%。 TPV 手术比心臟直视手术侵入性更小。
  • 2023年，球囊型经导管瓣膜细分市场占据大部分收益占有率，经导管肺动脉瓣市场预计在预测期内成长最快。
  • 主要企业包括 Boston Scientific Corporation、Braile Biomedica、Direct Flow Medical、Edwards Lifesciences Corporation、JenaValve Technology, Inc.、St. Jude Medical 和 VENUS MEDTECH。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 经导管肺动脉瓣市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 经导管肺动脉瓣市场分析工具
    • 波特的分析
    • PESTEL分析

第四章经导管肺动脉瓣市场：应用估算与趋势分析

  • 细分仪表板
  • 经导管肺动脉瓣市场：2023 年和 2030 年应用变化分析
  • 肺动脉狭窄
  • 肺逆流症
  • 肺动脉闭锁
  • 其他的

第五章经导管肺动脉瓣市场：技术评估与趋势分析

  • 细分仪表板
  • 经导管肺动脉瓣市场：2023 年和 2030 年技术变化分析
  • 球囊扩张经导管瓣膜
  • 自膨胀式经导管瓣膜

第六章经导管肺动脉瓣市场：最终用途估计与趋势分析

  • 细分仪表板
  • 经导管肺动脉瓣市场：2023 年和 2030 年最终用途变化分析
  • 成人
  • 儿科经导管瓣膜

第七章经导管肺动脉瓣市场：原料估算与趋势分析

  • 细分仪表板
  • 经导管肺动脉瓣市场：2023年及2030年原料变化分析
  • 合成
  • 组织工程

第八章经导管肺动脉瓣市场：区域估计和趋势分析

  • 2023年及2030年经导管肺动脉瓣市场占有率（按地区），百万美元
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 最新趋势与影响分析：主要市场参与企业
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Boston Scientific Corporation
    • Braile Biomedica
    • Artivion, Inc
    • Edwards Lifesciences Corporation
    • JenaValve Technology, Inc.
    • LivaNova PLC
    • Medtronic
    • Venus Medtech
    • Lepu Medical Technology
    • Jude Medical Inc.
简介目录
Product Code: GVR-1-68038-702-5

Transcatheter Pulmonary Valve Market Growth & Trends:

The global transcatheter pulmonary valve market size is expected to reach USD 100.6 million by 2030, registering to grow at a CAGR of 5.5% from 2024 to 2030 according to a new report by Grand View Research, Inc. The technological advancements pertaining to heart valve technologies, and increasing number of clinical trials pipeline by various public and private players are some of the crucial factors expected to boost the market over the forecast period.

In 2023, North America held the majority of market share of nearly 80.6% in the global market. Some of the major drivers are increasing prevalence of the various cardiovascular disorders, growing geriatric population with heart valve diseases such as pulmonary stenosis, pulmonary regurgitation, and others, and rising awareness regarding the benefits of transcatheter valves over surgical procedures. The growing number of patients suffering from long-term heart disorders, rising awareness about technologically advanced heart valve, and increasing healthcare expenditures and reimbursement policies for overall transcatheter valves are some of the key contributors to the growth of the market globally.

However, Asia Pacific is expected to show a growth in this market after 2019, as there will be several product launch in this region. The Asia Pacific region is expected to grow at a lucrative growth rate owing to the growth of many developing economies like Japan and China. These developing countries show a potential of growth due to various contributors such as the increasing aging population and growing prevalence of heart diseases. Moreover, the presence of a large pool of patients, developing healthcare infrastructure & services, increasing disposable income, and rising government funding are some of the factors that are expected to drive the market during the forecast period.

Transcatheter Pulmonary Valve Market Report Highlights:

  • Pulmonary stenosis dominated the market and accounted for a market share of 43.1% in 2023. TPV operations are less invasive in nature compared to open-heart surgery.
  • In 2023, balloon transcatheter valve segment held majority of the revenue share and is expected to be the fastest growing transcatheter pulmonary valve market during the forecast period
  • Some of the key players are Boston Scientific Corporation, Braile Biomedica, Direct Flow Medical, Edwards Lifesciences Corporation, JenaValve Technology, Inc., St. Jude Medical, and VENUS MEDTECH.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Transcatheter Pulmonary Valve Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Transcatheter Pulmonary Valve Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Transcatheter Pulmonary Valve Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Transcatheter Pulmonary Valve Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Pulmonary Stenosis
    • 4.3.1. Pulmonary Stenosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Pulmonary Regurgitation
    • 4.4.1. Pulmonary Regurgitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Pulmonary Atresia
    • 4.5.1. Pulmonary Atresia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Transcatheter Pulmonary Valve Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Transcatheter Pulmonary Valve Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Ballon Expanded Transcatheter Valve
    • 5.3.1. Ballon Expanded Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Self Expanded Transcatheter Valve
    • 5.4.1. Self Expanded Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Transcatheter Pulmonary Valve Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Transcatheter Pulmonary Valve Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Adult
    • 6.3.1. Adult Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Pediatric Transcatheter Valve
    • 6.4.1. Pediatric Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Transcatheter Pulmonary Valve Market: Raw Material Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Transcatheter Pulmonary Valve Market: Raw Material Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Synthetic
    • 7.3.1. Synthetic Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Tissue engineered
    • 7.4.1. Tissue engineered Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Transcatheter Pulmonary Valve Market: Regional Estimates & Trend Analysis

  • 8.1. Transcatheter Pulmonary Valve Market Share, By Region, 2023 & 2030, USD Million
  • 8.2. North America
    • 8.2.1. North America Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Sweden Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. China Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Thailand
      • 8.4.6.1. Thailand Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Boston Scientific Corporation
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Braile Biomedica
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Artivion, Inc
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. Edwards Lifesciences Corporation
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. JenaValve Technology, Inc.
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. LivaNova PLC
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Medtronic
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Venus Medtech
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. Lepu Medical Technology
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. Jude Medical Inc.
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives